He S - Search Results

1

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S. Antovic A, et al. Among authors: he s. Thromb Res. 2005;116(6):509-17. doi: 10.1016/j.thromres.2005.02.007. Thromb Res. 2005. PMID: 16181986

2

Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants.

He S, Bremme K, Kallner A, Blombäck M. He S, et al. Gynecol Obstet Invest. 1995;39(4):234-8. doi: 10.1159/000292417. Gynecol Obstet Invest. 1995. PMID: 7635366

3

Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia.

He S, Bremme K, Blombäck M. He S, et al. Blood Coagul Fibrinolysis. 1995 Dec;6(8):703-8. doi: 10.1097/00001721-199512000-00002. Blood Coagul Fibrinolysis. 1995. PMID: 8825219

4

Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia.

He S, Bremme K, Blombäck M. He S, et al. Blood Coagul Fibrinolysis. 1997 Jun;8(4):232-8. doi: 10.1097/00001721-199706000-00004. Blood Coagul Fibrinolysis. 1997. PMID: 9199820

5

Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia.

He S, Silveira A, Hamsten A, Blombäck M, Bremme K. He S, et al. Thromb Haemost. 1999 Apr;81(4):538-42. Thromb Haemost. 1999. PMID: 10235435

6

Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?

He S, Bremme K, Blombäck M. He S, et al. Blood Coagul Fibrinolysis. 1999 Apr;10(3):127-32. doi: 10.1097/00001721-199904000-00003. Blood Coagul Fibrinolysis. 1999. PMID: 10357006

7

A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results.

He S, Bremme K, Blombäck M. He S, et al. Thromb Res. 1999 Oct 15;96(2):145-56. doi: 10.1016/s0049-3848(99)00092-4. Thromb Res. 1999. PMID: 10574592 Clinical Trial.

8

Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system.

He S, Blombäck M, Yoo G, Sinha R, Henschen-Edman AH. He S, et al. Ann N Y Acad Sci. 2001;936:531-5. doi: 10.1111/j.1749-6632.2001.tb03540.x. Ann N Y Acad Sci. 2001. PMID: 11460511

9

A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work.

He S, Antovic A, Blombäck M. He S, et al. Thromb Res. 2001 Sep 1;103(5):355-61. doi: 10.1016/s0049-3848(01)00332-2. Thromb Res. 2001. PMID: 11553368

10

Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.

He S, Cao H, Magnusson CG, Eriksson-Berg M, Mehrkash M, Schenck-Gustafsson K, Blombäck M. He S, et al. Thromb Res. 2001 Aug 1;103(3):241-8. doi: 10.1016/s0049-3848(01)00320-6. Thromb Res. 2001. PMID: 11672586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,587 results

Search Page

Filters